Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck KGaA carves into MS R&D after a string of setbacks
Merck KGaA carves into MS R&D after a string of setbacks
Merck KGaA carves into MS R&D after a string of setbacks
Submitted by
admin
on February 23, 2015 - 10:16am
Source:
Fierce Biotech
News Tags:
Merck KGaA
MS
multiple sclerosis
R&D
Headline:
Merck KGaA carves into MS R&D after a string of setbacks
Do Not Allow Advertisers to Use My Personal information
